Why Pfizer and Moderna Won't Make As Much Extra Money From U.S. Booster Doses As You...

[cafead]

via

• The FDA and CDC have given a thumbs-up for third booster doses of mRNA vaccines in immunocompromised individuals, but this won't translate to a lot of extra revenue for Pfizer or Moderna.
• There's a relatively small market in the U.S. for booster doses under the current EUAs.
• The U.S. government has also already secured supply deals for more than enough doses to fully vaccinate every American and give a third booster dose.

article source